Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in OGI — Organigram Global Inc.

CIK 1423053 MIAMI, FL
Back to OGI Full portfolio

Position in OGI

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$75,046
+$56,974 QoQ
Shares Held
73,575
+445.5% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 69 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OGI Over Time

Shares Held

Position Value (USD)

Derivatives in OGI

reported options exposure · as of Jun 30, 2026
CallValue
$46,002
CallShares
45,100
PutValue
$14,892
PutShares
14,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names. OGI ranks #55 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in OGI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,002 45,100
2026-06-30 $14,892 14,600
2026-06-30 $75,046 73,575
2026-03-31 $171,252 127,800
2026-03-31 $18,072 13,487
2026-03-31 $25,326 18,900
2025-12-31 $32,928 19,600
2025-12-31 $837,903 498,752
2025-12-31 $204,288 121,600
2025-09-30 $48,314 23,800
2025-09-30 $488,476 240,629
2025-06-30 $55,350 41,000
2025-06-30 $446,789 330,955